Sociedad Americana de Hirudoterapia

Head and Neck Tumor Resection and Free Flap Reconstruction in Low-Volume Center

Observational published in Ear Nose Throat J (2020)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosSeguridad y control de infeccionesBrennan M et al. · Ear, nose, & throat journal, 2020

Abstract

OBJECTIVE: To determine the surgical outcomes of free tissue transfer surgery following head and neck tumor extirpation in a low-volume medical center. METHODS: Retrospective chart review of patients who underwent free tissue transfer surgery for head and neck cancer at Moanalua Medical Center from 2015 to 2018. MAIN OUTCOME OF MEASURE: Free flap failure rate and free flap-related complications. RESULTS: From 2015 to 2018, there were 27 free tissue transfer surgery (mean 6.75 flap surgery/year). There were 2 events of partial flap necrosis, and no cases of total flap loss. One patient required leech therapy for venous congestion. One patient required additional free flap surgery. Two patients developed orocutaneous fistula that resolved with local wound care. One patient developed malocclusion following mandible reconstruction using fibular free flap. Overall free flap success rate was 96%. CONCLUSION: This study supports the ability of small-volume centers to produce positive outcomes with few complications in head and neck cancer free flap reconstructive surgery. While the data are limited to a single surgical team in one care center, it provides additional support for the idea that there are factors beyond the surgical volume that determine outcome.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsFree Tissue FlapsHead and Neck NeoplasmsHospitals, Low-VolumeHumansPostoperative ComplicationsPlastic Surgery ProceduresRetrospective StudiesTreatment Outcome

Resumen

Retrospective series of 27 free-flap reconstructions for head and neck cancer at a low-volume center (mean 6.75 flaps/year). One patient required leech therapy for venous congestion; overall 96% free-flap success.

Por qué esto importa para la hirudoterapia

This retrospective chart review examined surgical outcomes of free tissue transfer following head and neck tumor resection at a single low-volume center (Moanalua Medical Center, 2015-2018), reporting a 96% free flap success rate across 27 cases. Notably, one patient required leech therapy for venous congestion, directly situating hirudotherapy within the reconstructive surgery complication-management armamentarium. For ASH's domain, this reinforces the established role of medicinal leeches as a salvage tool for venous congestion in free flap surgery, even in low-volume settings. The caveat is that leech therapy is mentioned only as a single clinical event without detail on technique, duration, or outcome specific to leeching; the study's primary focus is surgical volume-outcome relationships, not hirudotherapy efficacy.

Citación

Head and Neck Tumor Resection and Free Flap Reconstruction in Low-Volume Center.

Brennan M et al. · Ear, nose, & throat journal, 2020

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.